ARRHYTHMIAS IN PATIENTS WITH CHRONIC KIDNEY DISEASE RECEIVING HEMODIALYSIS TREATMENT
Ключевые слова:
hemodialysis, renal failure, coronary heart disease, arrhythmia.Аннотация
Cardiovascular diseases are one of the most significant predictors of mortality in patients with end-stage renal disease treated with chronic hemodialysis, and cause at least a third of all hospitalizations [Eisner D. et al., 2001; Johnston N. et al., 2008]. According to the US Renal Disease Registry, the five-year survival rate in the general population of patients on hemodialysis is 33.4% [U. S. Renal Data System, 2009]. More than half of the deaths of patients on renal replacement therapy are due to cardiovascular pathology, the mortality from which in patients on hemodialysis is 30-35 times higher compared to the general population [Zavy A.S. et al., 1998; Herzog S.A., 2003; U.S. Renal Data System, 2009]. A significant proportion of deaths in patients with end-stage renal disease receiving hemodialysis treatment are attributed to those associated with coronary heart disease [Foley R.N. et al., 1998a; Sarnak M.J. et al., 2003; Cheung A.K. et al., 2004]. The theoretical method of research was used. Many articles and dissertations by international scientists were analyzed, which were based on various books, dissertations, as well as electronic journals.
Библиографические ссылки
Косталанова Ю.В., Королева И.А., Давыдкин И.Л. и др. MALT-лимфома желудка: современное состояние проблемы // Эффективная фармакотерапия. Онкология, гематология и радиология. - 2013. - (4). - С. 26–29.
Маллаев М. М. Современные аспекты в диагностике и выбора тактики лечении при МАЛТ-лимфоме. Дис. … канд. мед. наук. – Т., 2019. - С. 124.
Мозговой С.И., Костенко М.Б., Кролевец Т.С., Ливзан М.А. Аутоиммунный гастрит в фокусе клинициста и морфолога // Фарматека. - 2019. - Т. 26. - № 2. - С. 121-129.
Amieva M., Peek R.M. Pathobiology of Helicobacter pylori–induced gastric cancer //Gastroenterology. – 2016. – V.150. – №. 1. – P. 64–78.
Camargo, M. C., Garcia, A., Riquelme, A., Otero, W., Camargo, C. A., Hernandez-Garcia, T., et al. (2014). The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America. Am. J. Gastroenterol. 109, 485–495. doi: 10.1038/ajg.2014.24.
Fallone, C. A., Chiba, N., van Zanten, S. V., Fischbach, L., Gisbert, J. P., Hunt, R. H., et al. (2016). The toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 151, 51-69. e14. doi: 10.1053/j.gastro.2016.04.006.
Ferreira R.M., Pereira-Marques J., Pinto-Ribeiro I. et al. Gastric microbial сommunity profiling reveals a dysbiotic cancerassociated microbiota // Gut. 2018. Vol. 67. № 2. P. 226–236.
Ismailova J.A., Yusupbekov A.A. Modern aspects to the problem of the prevalence of helicobacter pylori associated stomach diseases in Uzbekistan // Journal of Healthcare in Developing Countries (JHCDC). Selangor. –2021. – №1(2). – C. 28–30.
Graham D.Y. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer // World J. Gastroenterol. 2014. Vol. 20. №18. P. 5191–5204.
Kocazeybek, B., and Tokman, H. B. (2016). Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a systematic review. Helicobacter 21, 251–260. doi: 10.1111/hel.12272.
Wang, J., Xu, L., Shi, R., Huang, X., Li, S. W., Huang, Z., et al. (2011). Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis.Digestion 83, 253–260. doi: 10.1159/000280318
Wroblewski L.E., Peek R.M.Jr. Helicobacter pylori, cancer, and the gastric microbiota // Adv. Exp. Med. Biol. 2016. Vol. 908. P. 393–408.
Yokota S., Konno M., Fujiwara S.I. et al. Intrafamilial, preferentially mother-to-child and intraspousal, Helicobacter pylori infection in Japan determined by mutilocus sequence typing and random amplified polymorphic DNA fingerprinting // Helicobacter. 2015. Vol. 20. №5. P. 334–342.
Ismailova.J.A. Epidemiology of Helicobacter associated diseases of the gastrointestinal tract (GIT) in Uzbekistan. Local treatment protocols. // Clinical and experimental oncology -No2 (4), 2018, -Р.74-77
Ismailova J., Yusupbekov A., Karimov M. Distribution of genotypes helicobacter pylori in Uzbekistan. / Medical Science “Colloquium- journal’34(15). 2018 P.22-24
M.M. Karimov, S.T. Rustamova, Zh.A . Ismailova, U.K . Abdullaeva, Z.Z . Saatov. Diagnostic efficacy of C14 breath test in Helicobacter pyloriosis // Cardiovascular therapy and prevention. 2019. Vol. 18, Issue S1, P. 85-86
Исмаилова Ж.А. Эпидемиология хеликобактер ассоциированных заболеваний желудочно-кишечного тракта (ЖКТ) в Узбекистане. Локальные протоколы лечения. // Клиническая и экспериментальная онкология -№2(4), 2018, -Р.74-77.
Chan A.O., Peng J.Z., Lam S.K., Lai K.C., Yuen M.F., Cheung H.K.L., Kwong Y.L., Rashid A., Chan C.K., Wong B.C. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation // Gut. – 2006. – V.55. – №. 4. – P. 463–468.
Leja M., Park J.Y., Murillo R. et al. Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study // BMJ Open. 2017. Vol. 7. № 8. P. e016999.
Ford, A. C., Forman, D., Hunt, R. H., Yuan, Y., and Moayyedi, P. (2014). Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ 348:g3174. doi: 10.1136/bmj.g3174.
Mehmanov, S. R., Baimakov, S. R., Khodiev, K. S., Boltaev, S. S., Janibekov, S. S. N., & Babakulov, S. K. (2021). PRIMARY ANASTOMOSIS IN THE SURGERY OF COLON OBSTRUCTION OF TUMOR ETIOLOGY. Новый день в медицине, (1), 44-47.
Baymakov, S. R., Yunusov, S. S., Jamilov, U. R., Bobokulov, S. K., Boltaev, S. S., & Jonibekov, S. S. (2020). Our Experience in Treatment Acute Surgical Diseases of the Abdominal Cavity in Patients with Situs Inversus Viscerum (Transposition of Internal Organs). Indian Journal of Forensic Medicine & Toxicology, 14(4), 7753-7757.
Teshaev, O. R., Ismoilov, M. U., Baymakov, S. R., Babakulov, S. K., & Abdullaev, B. S. (2020). Modern approach to the treatment of cholelithiasis complicated by obstructive jaundice. European Journal of Molecular and Clinical Medicine, 7(10), 413-418.
Тилляшайхов, М., Хасанов, Ш., Абдикаримов, М., Бабакулов, Ш., & Абдусаматов, Н. (2012). Современные подходы деривации мочи после радикальной цистэктомии при раке мочевого пузыря. Журнал вестник врача, 1(03), 179-182.
BAYMAKOV, S., YUNUSOV, S., BOLTAEV, S., BABAKULOV, S., ASLANOV, Z., & JANIBEKOV, S. NEW DAY IN MEDICINE. NEW DAY IN MEDICINE Учредители: Бухарский государственный медицинский институт, ООО" Новый день в медицине",(6), 63-69.
Hamrаkulovich, B. S., Navruzovich, N. S., & Hamidullaevna, B. S. (2016). The basics of local clinical manifestations of superficial bladder cancer. European science review, (9-10), 75-77.
Бабакулов, Ш. Х., Тангриберганов, М. Р., & Бабакулова, Ш. Х. (2016). ХАРАКТЕРИСТИКА МИКРОСОСУДИСТОГО РУСЛА В ЗАВИСИМОСТИ ОТ ПРОГНОСТИЧЕСКИХ ФАКТОРОВ ПРИ ПОВЕРХНОСТНОМ РАКЕ МОЧЕВОГО ПУЗЫРЯ. Журнал теоретической и клинической медицины, (3), 142-144.
Hamrokulovich, B. S., Reyimberganovich, T. M., & Hamidullaevna, B. S. (2016). Specificity of micro-vascular density in superficial bladder cancer. European science review, (3-4), 63-64.
Naimov, O., Matmurodov, R., & Abdukodirov, E. (2019). Gastrointestinal disturbances in various forms of parkinsonism. Journal of the Neurological Sciences, 405, 187-188.
Juraev, R., Abdukodirov, E., Matmurodov, R., & Khalimova, K. (2019). Initial manifestations of Parkinson's disease in Uzbek nationality. Journal of the Neurological Sciences, 405, 302-303.
Matmurodov, R., Khalimova, K., & Abdukodirov, E. (2019). Cardiovascular disorders in parkinsonism depending on the form of the disease. Journal of the Neurological Sciences, 405, 198-199.
